The Bcl-2 family protein inhibitor, ABT-737, has substantial antimyeloma activity and shows synergistic effect with dexamethasone and melphalan

Suzanne Trudel, A. Keith Stewart, Zhihua Li, Yanjun Shu, Sheng Ben Liang, Young Trieu, Donna Reece, Josh Paterson, Dingyan Wang, Xiao Yan Wen

Research output: Contribution to journal › Article › peer-review

106 Scopus citations

Fingerprint

Dive into the research topics of 'The Bcl-2 family protein inhibitor, ABT-737, has substantial antimyeloma activity and shows synergistic effect with dexamethasone and melphalan'. Together they form a unique fingerprint.

Medicine & Life Sciences